Skip to content

Observation of the effect of a hemostatic air cushion with exhaust regulator valve in patients with arteriovenous internal fistula

Observation of the effect of a hemostatic air cushion with exhaust regulator valve in patients with arteriovenous internal fistula

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000033226
Enrollment
Unknown
Registered
2020-05-24
Start date
2020-05-26
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic renal failure

Interventions

Experimental group:Use of new hemostasis apparatus
Control Group:Traditional hemostasis method

Sponsors

the First Hospital of Jilin University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Chronic renal failure patients aged 18 to 80 years old; 2. Native Chinese, arteriovenous fistula; 3. Regular dialysis for more than 3 months, no abnormal hemostasis (prolonged hemostasis time or complications such as bleeding, hematoma and aneurysm) occurred in the last month; 4. Education level above primary school; 5. Clear mind, no other cognitive dysfunction; 6. Can cooperate with 20 minutes of operation training.

Exclusion criteria

Exclusion criteria: 1. Severe dysarthria, hearing impairment, cognitive impairment and other reasons lead to patients unable to cooperate with the scale evaluation; 2. Language disorder caused by consciousness disorder and general mental retardation; 3. Learning difficulties caused by congenital or juvenile diseases and resulting in language dysfunction; 4. Because of the damage of heart, liver, kidney and other important organs, the researchers think it is not suitable to participate in this study; 5. Patients with extensive aneurysms, excessive pressure of internal fistula, long-term oral anticoagulant drugs, or laboratory examination of platelet count abnormalities, coagulation dysfunction, who could not stop the treatment after being included in the study

Design outcomes

Primary

MeasureTime frame
Subcutaneous hematoma;Degree of bleeding;Block displacement;Hemostasis time;Satisfaction;

Countries

China

Contacts

Public ContactZhou Li

Blood Purification Center, the First Hospital of Jilin University

khyu1@163.com+86 15804301299

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026